Latest Commercialisation News

AnteoTech Ltd has completed a strategic review that refocuses its business on commercialising existing products, delivering $1.6 million in annual cost savings and expanding its sales pipeline in battery and life sciences markets.

Opyl Limited unveils a bold strategic pivot to enhance its AI-driven drug discovery platform, leveraging a vast proprietary dataset and leadership upgrades to redefine clinical trial innovation.

Botanix Pharmaceuticals has secured a US$30 million debt facility from Kreos Capital, bolstering its financial position to commercialize Sofdra™ and pursue platform expansion opportunities.

Omega Oil and Gas has extinguished a 3% royalty on its Queensland liquids production by paying TAG Oil US$1 million, clearing the way for greater commercial flexibility following promising flow tests at Canyon-1H.

Jade Gas Holdings has launched Mongolia’s inaugural horizontal Coal Bed Methane production wells at the Red Lake field, signaling a pivotal step in the country’s energy transition. The company also appoints Chris Whiteman as interim CEO amid strategic leadership changes.

Firebrick Pharma has unexpectedly withdrawn its planned share placement, raising questions about its capital strategy amid ongoing product launches.

Tivan Limited has received $150,000 in exploration grants from the Northern Territory Government to advance its promising Sandover Fluorite Project, supporting maiden drilling and metallurgical testwork.

Algorae Pharmaceuticals has secured a significant A$318,771 R&D tax incentive rebate from the Australian Taxation Office, providing a non-dilutive cash injection to advance its AI-driven drug discovery programs.

Clarity Pharmaceuticals reports that its Cu-SARTATE diagnostic agent significantly outperforms the current standard in detecting neuroendocrine tumours, paving the way for a pivotal Phase III study.

State Gas Limited has settled a land access dispute at its Rolleston West Project, enabling the company to resume drilling and flow testing activities. This development paves the way for advancing coal seam gas production using innovative technologies.

Proteomics International has published clinical validation results for PromarkerEso, a novel blood test that detects esophageal adenocarcinoma with remarkable accuracy, promising a non-invasive alternative to costly and uncomfortable endoscopy procedures.

Sparc Technologies has successfully closed its Share Purchase Plan, raising more than double its initial target, signaling strong shareholder confidence as it advances its green hydrogen and graphene projects.